儿童钝性胸主动脉损伤:TEVAR与开放修复的国家趋势
基于美国国家创伤数据库2007-2015年≤17岁钝性胸主动脉损伤患者,TEVAR使用率从15.4%升至27.1%,占干预的78.0%;与开放修复相比,TEVAR住院和ICU时间更短,但死亡率风险无差异。
要点
- 儿童钝性胸主动脉损伤中TEVAR使用率从2007年15.4%升至2015年27.1%。
- TEVAR患者住院和ICU时间短于开放修复,但合并创伤性脑损伤比例更高。
- TEVAR与开放修复的死亡风险无差异,长期疗效和并发症有待纵向研究。
核心结论
- 儿童钝性胸主动脉损伤中TEVAR使用率2007至2015年近乎翻倍,死亡风险与开放修复无差异。
- TEVAR与开放修复相比住院时间更短,但创伤性脑损伤比例更高。
研究设计与样本
- 回顾性队列研究,查询美国国家创伤数据库2007-2015年≤17岁钝性胸主动脉损伤患者。
- 共识别650例儿童钝性胸主动脉损伤患者,其中159例(24.5%)接受干预。
主要发现
- 159例干预患者中124例(78.0%)接受TEVAR,35例(22.0%)接受开放修复。
- TEVAR使用率从2007年15.4%升至2015年27.1%(P < 0.001)。
- TEVAR患者创伤性脑损伤比例高于开放修复(63.7% vs. 37.1%,P = 0.005)。
- TEVAR患者住院时间(16.4 vs. 21.4天,P = 0.02)和ICU时间(10.1 vs. 12.2天,P = 0.01)均短于开放修复。
- TEVAR与开放修复死亡风险无差异(OR 1.20,CI 0.29-5.01,P = 0.80),按≤14岁和15-17岁分层后仍无差异。
临床怎么用
- 儿童钝性胸主动脉损伤可考虑TEVAR以缩短住院和ICU时间,但需权衡创伤性脑损伤等合并症。
- TEVAR与开放修复死亡风险相当,选择术式应综合评估患者伤情和合并损伤。
局限性
- 需纵向研究评估TEVAR在儿童中的长期疗效及并发症,包括再干预、内漏和再次手术需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blunt thoracic aortic injury (BTAI) occurs in <1% of all trauma admissions. Thoracic endovascular aortic repair (TEVAR) has become the preferred treatment modality in adult patients with BTAI, but its use in pediatrics is currently not supported by device manufacturers and lacks United States Food and Drug Administration approval. We hypothesized that there would also be an increased use of TEVAR in the pediatric population, thus conferring a lower risk of mortality compared with open thoracic aortic repair (OTAR). METHODS: The National Trauma Data Bank (2007-2015) was queried for patients ≤17 years with BTAI. The primary outcomes were the incidences of TEVAR and OTAR. Secondary outcome was risk of mortality in those undergoing intervention. A multivariable logistic regression model was used to determine the risk of mortality in OTAR versus TEVAR. RESULTS: We identified 650 pediatric BTAI patients with 159 (24.5%) undergoing intervention. Of these, 124 underwent TEVAR (78.0%) and 35 (22.0%) underwent OTAR. The rate of TEVAR steadily increased from 2007 to 2015 (15.4% vs. 27.1%, P < 0.001). Patients receiving OTAR and TEVAR had a similar injury severity score and rate of hypotension on admission (P > 0.05). Compared with OTAR, TEVAR patients had a higher rate of any traumatic brain injury (TBI) (63.7% vs. 37.1%, P = 0.005) and shorter hospital and intensive care unit length of stay (LOS) (16.4 vs. 21.4 days, P = 0.02; 10.1 vs. 12.2 days, P = 0.01). TEVAR and OTAR, even when stratified by ≤14 years and 15-17 years, had no difference in risk for mortality (odds ratio 1.20, confidence interval 0.29-5.01, P = 0.80). CONCLUSIONS: The rate of TEVAR in pediatric BTAI nearly doubled from 2007 to 2015. Compared with OTAR, TEVAR was associated with a shorter hospital LOS despite a higher rate of TBI. There was no difference in risk for mortality between TEVAR and OTAR. Longitudinal studies to determine the long-term efficacy and complication rates, including reintervention, development of endoleak, and/or need for further operations, are needed as this technology is being rapidly adopted for pediatric trauma patients.
引用
- Hasjim BJ, Grigorian A, Barrios C, et al. National Trends of Thoracic Endovascular Aortic Repair versus Open Thoracic Aortic Repair in Pediatric Blunt Thoracic Aortic Injury. Ann Vasc Surg. 2019. PMID: 30802562. doi:10.1016/j.avsg.2018.12.094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。